ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 148 filers reported holding ARCUS BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $10,519,884 | +23.9% | 576,748 | +40.5% | 0.32% | +23.1% |
Q4 2022 | $8,488,726 | -5.5% | 410,480 | +19.6% | 0.26% | -11.3% |
Q3 2022 | $8,982,000 | +41.6% | 343,335 | +37.1% | 0.29% | +35.0% |
Q2 2022 | $6,345,000 | -11.1% | 250,385 | +10.8% | 0.22% | +22.6% |
Q1 2022 | $7,134,000 | +28.3% | 226,050 | +64.5% | 0.18% | +55.3% |
Q4 2021 | $5,560,000 | +52.1% | 137,387 | +31.0% | 0.11% | +65.2% |
Q3 2021 | $3,656,000 | – | 104,848 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $29,404,284 | 19.15% |
Decheng Capital Management III (Cayman), LLC | 869,790 | $15,864,970 | 6.40% |
Octagon Capital Advisors LP | 2,172,000 | $39,617,280 | 5.70% |
Boxer Capital, LLC | 1,432,200 | $26,123 | 1.28% |
PFM Health Sciences, LP | 1,559,947 | $28,453,433 | 1.26% |
SECTORAL ASSET MANAGEMENT INC | 293,646 | $5,356,103 | 1.03% |
DAFNA Capital Management LLC | 175,217 | $3,195,958 | 0.96% |
Ikarian Capital, LLC | 230,000 | $4,195,200 | 0.95% |
Tejara Capital Ltd | 50,000 | $912,000 | 0.47% |
Capital Impact Advisors, LLC | 20,501 | $373,938 | 0.46% |